Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001204241 | SCV001375440 | likely pathogenic | Ornithine carbamoyltransferase deficiency | 2019-09-12 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Trp193 amino acid residue in OTC. Other variant(s) that disrupt this residue have been observed in individuals with OTC-related conditions (PMID: 16786505, 19138872, 12402347), which suggests that this may be a clinically significant amino acid residue. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has been observed in individuals reportedly affected with ornithine transcarbamylase (OTC) deficiency (PMID: 16786505, 17565723). ClinVar contains an entry for this variant (Variation ID: 97252). This variant is not present in population databases (ExAC no frequency). This sequence change replaces tryptophan with arginine at codon 193 of the OTC protein (p.Trp193Arg). The tryptophan residue is highly conserved and there is a moderate physicochemical difference between tryptophan and arginine. |
Gen |
RCV000083494 | SCV000115580 | pathogenic | not provided | no assertion criteria provided | not provided | Converted during submission to Pathogenic. |